Eevia Health Plc partners up to enter 5-billion-euro eye-health market
Eevia Health Plc (”Eevia” or ”The Company”) received a letter of Intent with a global leader in eye health for a market launch in 2025 of Retinari™, a new game-changing eye-health product. To seek a 100 MEUR market opportunity, Eevia is partnering up with leading scientists to a new Scientific Advisory Board, initiating a safety study, and filing two new patent applications on the product.Following remarkably positive results of Eevia’s lead development product Retinari™ in a human primary cell study last year, Eevia received a Letter of Intent from a leading eye health company to work